Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyu Guo

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Translational Lung Cancer Research|December 13, 2024
Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapyPengxin Zhang, Shouliang Ding, Kangqiang Peng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2022
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapyDaQuan Wang, Bo Qiu, HaoQiang He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase I StudyRui Zhou, FangJie Liu, HongMei Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2023
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)Rui Zhou, Bo Qiu, Mai Xiong, et al.
Frontiers in Oncology|October 24, 2022
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignanciesFanJun Meng, XinLei Ai, Bin Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 29, 2022
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung CancerBo Qiu, Yu Xi, FangJie Liu, et al.
Practical Radiation Oncology|July 2, 2020
Quantifying the Interfractional motion of Esophagus Using Daily Cone Beam Computed Tomography with Oral Contrast During Radiation Therapy for Locally Advanced Non-Small Cell Lung CancerBo Qiu, ShiPei Lu, Bin Wang, et al.
Clinical and Translational Radiation Oncology|March 13, 2023
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastasesShouliang Ding, Biaoshui Liu, Shiyang Zheng, et al.
Journal of the American Chemical Society|March 22, 2022
Catalytic Performance and Near-Surface X-ray Characterization of Titanium Hydride Electrodes for the Electrochemical Nitrate Reduction ReactionMatthew J Liu, Jinyu Guo, Adam S Hoffman, et al.
Nature Communications|March 2, 2025
BOOST: a robust ten-fold expansion method on hour-scaleJinyu Guo, Hui Yang, Chixiang Lu, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Translational Lung Cancer Research|December 13, 2024
Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapyPengxin Zhang, Shouliang Ding, Kangqiang Peng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2022
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapyDaQuan Wang, Bo Qiu, HaoQiang He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase I StudyRui Zhou, FangJie Liu, HongMei Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2023
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)Rui Zhou, Bo Qiu, Mai Xiong, et al.
Frontiers in Oncology|October 24, 2022
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignanciesFanJun Meng, XinLei Ai, Bin Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 29, 2022
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung CancerBo Qiu, Yu Xi, FangJie Liu, et al.
Practical Radiation Oncology|July 2, 2020
Quantifying the Interfractional motion of Esophagus Using Daily Cone Beam Computed Tomography with Oral Contrast During Radiation Therapy for Locally Advanced Non-Small Cell Lung CancerBo Qiu, ShiPei Lu, Bin Wang, et al.
Clinical and Translational Radiation Oncology|March 13, 2023
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastasesShouliang Ding, Biaoshui Liu, Shiyang Zheng, et al.
Journal of the American Chemical Society|March 22, 2022
Catalytic Performance and Near-Surface X-ray Characterization of Titanium Hydride Electrodes for the Electrochemical Nitrate Reduction ReactionMatthew J Liu, Jinyu Guo, Adam S Hoffman, et al.
Nature Communications|March 2, 2025
BOOST: a robust ten-fold expansion method on hour-scaleJinyu Guo, Hui Yang, Chixiang Lu, et al.
Pageof 7